-+ 0.00%
-+ 0.00%
-+ 0.00%

*Lexeo Therapeutics : José Manuel Otero, PhD Appointed Oper Chief, Transitioning From Role as Chief Technical Officer >LXEO

Dow Jones·01/27/2026 12:45:00

Please log in to view news